rs201278558
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 11P and 1B. PM2PP3PP5_Very_StrongBP4
The NM_003038.5(SLC1A4):c.766G>A(p.Glu256Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,613,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
SLC1A4
NM_003038.5 missense
NM_003038.5 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 10.0
Genes affected
SLC1A4 (HGNC:10942): (solute carrier family 1 member 4) The protein encoded by this gene is a sodium-dependent neutral amino acid transporter for alanine, serine, cysteine, and threonine. Defects in this gene have been associated with developmental delay, microcephaly, and intellectual disability. [provided by RefSeq, Jan 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_addAF, BayesDel_noAF, Cadd, Dann, Eigen, MutationAssessor, phyloP100way_vertebrate [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
PP5
Variant 2-65010729-G-A is Pathogenic according to our data. Variant chr2-65010729-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 265259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.2571743). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC1A4 | NM_003038.5 | c.766G>A | p.Glu256Lys | missense_variant | 4/8 | ENST00000234256.4 | NP_003029.2 | |
SLC1A4 | NM_001348406.2 | c.106G>A | p.Glu36Lys | missense_variant | 4/8 | NP_001335335.1 | ||
SLC1A4 | NM_001348407.2 | c.106G>A | p.Glu36Lys | missense_variant | 4/8 | NP_001335336.1 | ||
SLC1A4 | NM_001193493.2 | c.106G>A | p.Glu36Lys | missense_variant | 4/7 | NP_001180422.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC1A4 | ENST00000234256.4 | c.766G>A | p.Glu256Lys | missense_variant | 4/8 | 1 | NM_003038.5 | ENSP00000234256.3 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
16
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000235 AC: 59AN: 251122Hom.: 0 AF XY: 0.000177 AC XY: 24AN XY: 135698
GnomAD3 exomes
AF:
AC:
59
AN:
251122
Hom.:
AF XY:
AC XY:
24
AN XY:
135698
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000125 AC: 182AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.000131 AC XY: 95AN XY: 727142
GnomAD4 exome
AF:
AC:
182
AN:
1461686
Hom.:
Cov.:
31
AF XY:
AC XY:
95
AN XY:
727142
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000105 AC: 16AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74350
GnomAD4 genome
AF:
AC:
16
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
21
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome Pathogenic:5
Pathogenic, no assertion criteria provided | clinical testing | Pediatric Genetics Clinic, Sheba Medical Center | May 13, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | New York Genome Center | May 29, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Nov 10, 2020 | - - |
Pathogenic, criteria provided, single submitter | research | HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology | Jun 08, 2017 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 2020 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 03, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 256 of the SLC1A4 protein (p.Glu256Lys). This variant is present in population databases (rs201278558, gnomAD 0.5%). This missense change has been observed in individual(s) with spastic tetraplegia, thin corpus callosum, and progressive microcephaly (PMID: 25930971, 26041762, 26138499). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 265259). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC1A4 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects SLC1A4 function (PMID: 26041762). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25930971, 26138499, 25256405, 27193218, 29652076, 26041762) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 19, 2024 | The c.766G>A (p.E256K) alteration is located in coding exon 4 of the SLC1A4 gene. This alteration results from a G to A substitution at nucleotide position 766, causing the glutamic acid (E) at amino acid position 256 to be replaced by a lysine (K). Based on data from gnomAD, the A allele has an overall frequency of 0.022% (62/282524) total alleles studied. The highest observed frequency was 0.473% (49/10356) of Ashkenazi Jewish alleles. This is a known founder variant in the Ashkenazi Jewish population. This variant has been identified in the homozygous state and/or in conjunction with other SLC1A4 variant(s) in individual(s) with features consistent with SLC1A4-related spastic tetraplegia, thin corpus callosum, and progressive microcephaly and segregated with disease in at least one family (Damseh, 2015; Srour, 2015). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
0.99
.;D
Vest4
MVP
MPC
0.79
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at